InMode is a medical devices business based in the US. InMode shares (INMD) are listed on the NASDAQ and all prices are listed in US Dollars. InMode employs 581 staff and has a trailing 12-month revenue of around $416.6 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $15.65 |
|---|---|
| 52-week range | $15.41 - $39.48 |
| 50-day moving average | $17.09 |
| 200-day moving average | $19.95 |
| Wall St. target price | $21.00 |
| PE ratio | 9.659 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $1.73 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $15.65 from 2024-09-05
| 1 week (2024-08-30) | -6.34% |
|---|---|
| 1 month (2024-08-06) | -7.51% |
| 3 months (2024-06-06) | -14.81% |
| 6 months (2024-03-06) | -31.24% |
| 1 year (2023-09-06) | -60.28% |
|---|---|
| 2 years (2022-09-06) | -48.84% |
| 3 years (2021-09-03) | 133.78 |
| 5 years (2019-09-06) | 24.14 |
Valuing InMode stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of InMode's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
InMode's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, InMode shares trade at around 10x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
InMode's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.9004. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into InMode's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
InMode's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $134.7 million.
The EBITDA is a measure of a InMode's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $416.6 million |
|---|---|
| Operating margin TTM | 21.18% |
| Gross profit TTM | $380.8 million |
| Return on assets TTM | 10.51% |
| Return on equity TTM | 21.05% |
| Profit margin | 35.81% |
| Book value | $8.96 |
| Market Capitalization | $1.3 billion |
TTM: trailing 12 months
We're not expecting InMode to pay a dividend over the next 12 months.
InMode's shares were split on a 2:1 basis on 30 September 2021. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your InMode shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for InMode shares which in turn could have impacted InMode's share price.
Over the last 12 months, InMode's shares have ranged in value from as little as $15.41 up to $39.48. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while InMode's is 2.175. This would suggest that InMode's shares are significantly more volatile than the average for this exchange and represent a higher risk.
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017.
Use this calculator to quickly see potential outcomes of your options trades.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Check out the best-performing ETFs so far in 2024.